Company Filing History:
Years Active: 2015
Title: Cord Dohrmann: Innovator in Pancreatic Dysfunction Treatment
Introduction
Cord Dohrmann is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of pancreatic dysfunction. His innovative work has the potential to impact the lives of many individuals suffering from related disorders.
Latest Patents
Cord Dohrmann holds a patent for "Screening methods for compounds useful for treating pancreatic dysfunction." This invention discloses polynucleotides that identify and encode various proteins, including DP119, DP444, DP810, DP685, WE474, DP160, RA977, and RA770. The patent outlines novel functions for these proteins and provides compositions aimed at treating, alleviating, and preventing pancreatic dysfunction, such as diabetes, hyperglycemia, and impaired glucose tolerance.
Career Highlights
Cord Dohrmann is associated with Evotec International GmbH, a company known for its commitment to advancing drug discovery and development. His work at Evotec has allowed him to focus on innovative solutions for complex medical challenges.
Collaborations
Cord collaborates with Matthias Austen, contributing to the advancement of research in their field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Cord Dohrmann's contributions to the treatment of pancreatic dysfunction through his patented inventions highlight his role as a key innovator in medical research. His work continues to pave the way for new therapeutic approaches that could benefit many patients.